As of May 28
| +0.03 / +2.22%|
The 1 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +697.10% increase from the last price of 1.38.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.